RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript
RxSight, Inc. misses on earnings expectations. Reported EPS is $-0.24699 EPS, expectations were $-0.17.
Rxsight Inc. (RXST)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 3,442,825 | $177,580,914 | +2% | 2.25% |
| 2. | Atika Capital Brad Farber | 414,000 | $21,354,119 | -7% | 2.1% |
| 3. | Parkman Healthcare Partners Greg Martinez | 412,432 | $21,273,243 | -20% | 2.61% |
| 4. | Driehaus Capital Richard Driehaus | 403,795 | $20,827,746 | -24% | 0.2% |
| 5. | No Street Capital Jeff Osher | 375,000 | $19,342,500 | -12% | 1.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $51.29 | 4,000 | 29,840 | 2024-02-14 | Filing | ||
| $50.38 | 4,000 | 25,840 | 2024-02-12 | Filing | ||
| $12.50 | 480,000 | Director | 980,000 | 2023-02-10 | Filing | |
| $12.49 | 8,150 | Director | 14,009 | 2021-11-17 | Filing | |
| $13.69 | 1,372 | Officer | 1,372 | 2021-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.15 | 40,000 | 764,610 | 2024-05-03 | Filing | ||
| $53.04 | 380 | 13,938 | 2024-05-01 | Filing | ||
| $52.68 | 9,620 | 14,318 | 2024-05-01 | Filing | ||
| $51.50 | 543 | 8,402 | 2024-04-01 | Filing | ||
| $50.37 | 200 | 8,945 | 2024-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,395,672 | $96,593,495 | 0.14% | |
| 2. | 2,076,470 | $83,723,269 | 0% | |
| 3. | 1,484,010 | $59,835,282 | 0% | |
| 4. | 1,186,477 | $47,838,753 | 0% | |
| 5. | 1,073,062 | $43,265,884 | 0% |
News See All
RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
RxSight, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.36.
RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
RxSight, Inc. (NASDAQ:RXST) Q1 2023 Earnings Call Transcript
Operator: Welcome to the RxSight First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the RxSight Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
RxSight, Inc. (NASDAQ:RXST) Q3 2022 Earnings Call Transcript
Operator: Hello and thank you for standing by. Welcome to the RxSight Third Quarter 2022 Earnings Conference Call. At this time, all the participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Jim Chanos, Dan Sundheim, Anthony Scaramucci, Nelson Peltz, Odey Asset Management, Pool Corporation (POOL), Rxsight Inc (RXST), and More
Jim Chanos blasted meme-stock traders as immature and petulant in a tweet this week.